Genome Editing in Neurosciences.
Saved in:
Superior document: | Research and Perspectives in Neurosciences Series |
---|---|
: | |
TeilnehmendeR: | |
Place / Publishing House: | Cham : : Springer International Publishing AG,, 2017. ©2017. |
Year of Publication: | 2017 |
Edition: | 1st ed. |
Language: | English |
Series: | Research and Perspectives in Neurosciences Series
|
Online Access: | |
Physical Description: | 1 online resource (129 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 05377nam a22004453i 4500 | ||
---|---|---|---|
001 | 5006422738 | ||
003 | MiAaPQ | ||
005 | 20240229073837.0 | ||
006 | m o d | | ||
007 | cr cnu|||||||| | ||
008 | 240229s2017 xx o ||||0 eng d | ||
020 | |a 9783319601922 |q (electronic bk.) | ||
020 | |z 9783319601915 | ||
035 | |a (MiAaPQ)5006422738 | ||
035 | |a (Au-PeEL)EBL6422738 | ||
035 | |a (OCoLC)1004664421 | ||
040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
050 | 4 | |a RB155-155.8 | |
082 | 0 | |a 616.80442 | |
100 | 1 | |a Jaenisch, Rudolf. | |
245 | 1 | 0 | |a Genome Editing in Neurosciences. |
250 | |a 1st ed. | ||
264 | 1 | |a Cham : |b Springer International Publishing AG, |c 2017. | |
264 | 4 | |c ©2017. | |
300 | |a 1 online resource (129 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 1 | |a Research and Perspectives in Neurosciences Series | |
505 | 0 | |a Intro -- Preface -- Contents -- List of Contributors -- In Vitro Modeling of Complex Neurological Diseases -- Introduction -- Induced Pluripotent Stem Cells to Model Complex Diseases -- Gene Editing to Generate Genetically Controlled Disease Models -- Functional Role of GWAS-Identified Risk Variants in Complex Disease -- Epigenomic Signatures to Prioritize GWAS-Identified Risk Variants -- Functional Analysis of Parkinsonś Disease-Associated Risk Variants -- Identification of Parkinsonś Disease-Associated Risk Variants in Brain-Specific Enhancer Elements -- Allele-Specific Gene Expression as a Robust Read-Out to Analyze Cis-Regulatory Effects -- Functional Analysis of Parkinsonś-Associated Risk Variants -- Mechanistic Study of Sporadic Diseases: Conclusions -- References -- Aquatic Model Organisms in Neurosciences: The Genome-Editing Revolution -- Introduction -- Zebrafish: With the CRiSPR-Cas9 System, Forward Genetic Screens Are Back Again -- Optimizing the Cripsr-Cas9 System in Transparent Marine Animals -- More and More Aquatic Model Organisms for Diversified Uses -- In Biomedical Research, Why and How Should We Use Aquatic Models to Study Diseases of the Nervous System? -- A Short Natural History of the Nervous System: Several Questions on Its Origin -- Conclusion -- References -- Genome-Wide Genetic Screening in the Mammalian CNS -- Introduction -- Genome-Wide Viral Library Preparation and Delivery -- Interpretation of Results -- Future Directions -- References -- CRISPR/Cas9-Mediated Knockin and Knockout in Zebrafish -- CRISPR/Cas9 and Gal4/UAS Combination for Cell-Specific Gene Inactivation -- Crispr/Cas9-Mediated Knockin Approaches in Zebrafish -- References -- Dissecting the Role of Synaptic Proteins with CRISPR -- Introduction -- Genome Editing Using CRISPR/Cas9 -- Practical Considerations for the Use of CRISPR/Cas9. | |
505 | 8 | |a The Use of CRISPR/Cas9 in Neurons: Proof of Concept -- Conclusions and Future Perspectives -- References -- Recurrently Breaking Genes in Neural Progenitors: Potential Roles of DNA Breaks in Neuronal Function, Degeneration and Cancer -- References -- Neuroscience Research Using Non-human Primate Models and Genome Editing -- Introduction -- Characteristics of the Common Marmoset -- Advantages of Using Common Marmosets for Biomedical Research -- Transgenic Techniques and Genome Editing Technology for Marmoset Research -- Future Perspectives -- References -- Multiscale Genome Engineering: Genome-Wide Screens and Targeted Approaches -- Introduction -- Top-Down Approaches Using Genome-Wide CRISPR Screens -- Bottom-Up Approaches Using Exome Sequencing in Autism -- References -- Using Genome Engineering to Understand Huntingtonś Disease -- Huntington ́Disease -- Gene Editing Enzymes -- Uses for Gene Editing to Understand Human Diseases -- Gene Editing In Vivo to Treat Genetic Diseases -- Conclusion -- References -- Therapeutic Gene Editing in Muscles and Muscle Stem Cells -- Duchenne Muscular Dystrophy -- Current Gene-Targeted Therapeutic Strategies for DMD -- Challenges for Therapeutic Exon Skipping and Microdystrophin Delivery Strategies -- Gene-Editing Approaches to Restore Dystrophin Function in DMD -- Remaining Challenges for Therapeutic Development of DMD-CRISPR -- Challenges of DMD-CRISPR Delivery -- Potential Immune Response to Restored Dystrophin Protein -- Pre-existing and Acquired Immunity to Cas9 -- Assessing Mutagenic Events at On-Target and Off-Target Sites -- Enabling HR for Precise Repair of Dmd -- Gene-Editing Therapy in Combination with AONs or Microdystrophin -- Possible Application of CRISPR-mediated gene editing Strategies in Other Diseases -- Conclusions and Perspective -- References. | |
588 | |a Description based on publisher supplied metadata and other sources. | ||
590 | |a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
655 | 4 | |a Electronic books. | |
700 | 1 | |a Zhang, Feng. | |
700 | 1 | |a Gage, Fred. | |
776 | 0 | 8 | |i Print version: |a Jaenisch, Rudolf |t Genome Editing in Neurosciences |d Cham : Springer International Publishing AG,c2017 |z 9783319601915 |
797 | 2 | |a ProQuest (Firm) | |
830 | 0 | |a Research and Perspectives in Neurosciences Series | |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6422738 |z Click to View |